Benzinga
Benzinga
Benzinga
venerdì, settembre 18

Ecolab Inc

ECLNYSE
Trade with Public
Trade with Public
$271.68
-2.40-0.88%
In chiusura: Sep 16, 5:00 PM EST
$271.68
-2.40-0.88%
Pre-mercato: 6:54 AM EST
Dividendo: La data di stacco del dividendo è stata 3 giorni fa
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoDividendiConfrontaRapporto azionario

Ecolab Financials

Ecolab (ECL) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Ecolab Flexes Pricing Muscle, Lifts 2026 Outlook

Ecolab (ECL) stock jumps 4% after Q2 earnings beat estimates with $2.09 EPS and $4.42B revenue. See Q2 details & full-year outlook.
Kaustubh Bagalkote

PRO
CORRECTION: Ecolab Raises FY2026 Adj EPS Guidance from $8.03-$8.23 to $8.05-$8.25 vs $8.22 Est

Ecolab (NYSE:ECL) raises FY2026 Adj EPS guidance from $8.03-$8.23 to $8.05-$8.25 vs $8.22 analyst estimate..
Benzinga Newsdesk

PRO
Ecolab Sees Q3 Adj EPS $2.13-$2.23 vs $2.18 Est

Ecolab (NYSE:ECL) is looking for Q3 Adj EPS of $2.13-$2.23 vs $2.18 analyst estimate..
Benzinga Newsdesk

PRO
Ecolab Q2 Adj. EPS $2.09 Beats $2.08 Estimate, Sales $4.415B Beat $4.389B Estimate

Ecolab (NYSE:ECL) reported quarterly earnings of $2.09 per share which beat the analyst consensus estimate of $2.08 by 0.48 percent. This is a 10.58 percent increase over earnings of $1.89 per share from the same period
Benzinga Newsdesk

PRO
Ecolab Updates 2026 Adjusted EPS Guidance To $8.03-$8.23, Sees 7%-9% EPS Growth YOY; Expects $0.20/Share Q3 And Q4 CoolIT Impact; Expects Organic Sales Growth Of 6%-7% In Second Half 2026; Adjusted Diluted EPS Growth Of 4% To 5% In Second Half Of Year; Beyond 2026, Ecolab Expects Organic Sales To Grow 5% To 7%

Ecolab Updates 2026 EPS Guidance to Include CoolIT SystemsReflecting the close of the CoolIT acquisition and a short-term impact of non-cash amortization and financing costs, Ecolab expects 2026 adjusted diluted EPS in
Benzinga Newsdesk

What's Going On With Ecolab Stock Tuesday?

Ecolab beats Q1 revenue estimates, reaffirms full-year guidance. Strong demand in life sciences and tech drives results.
Kaustubh Bagalkote

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved